Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Focal Adhesion WP306,9.658894058032995e-08,3.458965209634255,55.87197873457315,"['ITGB1', 'GSK3B', 'LAMA5', 'LAMA2', 'LAMA4', 'ITGA2B', 'PXN', 'LAMA3', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'LAMC1', 'ARHGAP35', 'IGF1R', 'RAP1A', 'AKT3', 'ITGAV', 'VASP', 'VAV3', 'PDGFRB', 'PRKCB', 'EGF', 'BRAF', 'PTK2', 'MAPK10', 'PIK3CA', 'COL5A2', 'ITGA8', 'SOS1', 'ITGA9']",4.4237734785791115e-05,0,0,30
2,Small cell lung cancer WP4658,1.810542423095777e-06,4.207673018201668,55.633364877695094,"['ITGB1', 'LAMA5', 'LAMA2', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3CD', 'PIK3R3', 'LAMC1', 'PIK3CB', 'FHIT', 'PTK2', 'NFKB1', 'NFKBIA', 'PIK3CA', 'TRAF3', 'AKT3', 'RARB', 'ITGAV']",0.000414614214888933,0,0,19
3,ErbB signaling pathway WP673,1.3158720933078348e-05,3.735870782024628,41.985306695464956,"['GSK3B', 'MAP2K4', 'PRKCB', 'EGF', 'GAB1', 'PIK3CD', 'PIK3R3', 'NRG1', 'BRAF', 'PIK3CB', 'PTK2', 'MAPK10', 'NRG3', 'PIK3CA', 'AKT3', 'ABL2', 'SOS1', 'SOS2']",0.002008898062449961,0,0,18
4,Chemokine signaling pathway WP3929,3.3698192733087677e-05,3.1759803921568626,32.706456805182285,"['VAV3', 'GSK3B', 'PRKCB', 'PXN', 'PIK3R3', 'PIK3CD', 'BRAF', 'PIK3CB', 'RASGRP2', 'PTK2', 'NFKB1', 'NFKBIA', 'ADCY9', 'RAP1A', 'PLCB4', 'PIK3CA', 'AKT3', 'JAK2', 'SOS1', 'SOS2']",0.002341655346127442,0,0,20
5,Non-small cell lung cancer WP4255,3.8145449770468145e-05,3.959768363303871,40.2870954586438,"['CRABP2', 'PRKCB', 'EGF', 'PIK3CD', 'PIK3R3', 'BRAF', 'PIK3CB', 'STK4', 'FHIT', 'PIK3CA', 'AKT3', 'RARB', 'SOS1', 'SOS2', 'PDK1']",0.002341655346127442,0,0,15
6,Development of ureteric collection system WP5053,4.041025608067387e-05,7.102077906342764,71.8476522747158,"['RET', 'ITGB1', 'GRIP1', 'FRAS1', 'GREB1L', 'ITGA8', 'RARB', 'GFRA1', 'SLIT2']",0.002341655346127442,0,0,9
7,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,4.068265470726648e-05,2.4019750112900797,24.283267742376214,"['ITGB1', 'GSK3B', 'LAMA5', 'LAMA2', 'COL11A1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3CD', 'PIK3CB', 'LAMC1', 'EFNA5', 'HIF1A', 'ACACA', 'IGF1R', 'GYS2', 'AKT3', 'ITGAV', 'JAK2', 'PPARGC1A', 'PDGFRB', 'EGF', 'PTK2', 'TBC1D1', 'FGF14', 'PIK3CA', 'COL5A2', 'ITGA8', 'SOS1', 'FGF12', 'ITGA9']",0.002341655346127442,0,0,31
8,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,4.090227678825226e-05,3.7158391758477607,37.54604604609436,"['PDGFRB', 'GSK3B', 'PRKCB', 'EGF', 'GAB1', 'PIK3CD', 'PIK3R3', 'NRG1', 'BRAF', 'PIK3CB', 'IGF1R', 'PIK3CA', 'AKT3', 'JAK2', 'SOS1', 'SOS2']",0.002341655346127442,0,0,16
9,Phosphoinositides metabolism WP4971,5.353015616901495e-05,4.743193971803597,46.65057153811746,"['MTMR10', 'MTMR2', 'PIKFYVE', 'PLCB4', 'MTMR3', 'PIK3CA', 'MTMR8', 'PIK3CD', 'PIP5K1B', 'PIK3CB', 'SBF2', 'MTM1']",0.002724090169489872,0,0,12
10,PI3K-Akt signaling pathway WP4172,0.00012968770171196668,2.269450161717142,20.312444270947747,"['ITGB1', 'GSK3B', 'LAMA5', 'LAMA2', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'LAMC1', 'EFNA5', 'IGF1R', 'GYS2', 'AKT3', 'ITGAV', 'JAK2', 'PDGFRB', 'EGF', 'PTK2', 'NFKB1', 'FGF14', 'PIK3CA', 'COL6A1', 'ITGA8', 'PKN2', 'SOS1', 'FGF12', 'SOS2', 'ITGA9']",0.005939696738408074,0,0,30
11,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.00014349677007429153,5.747535677504781,50.8610814016903,"['PLCB4', 'PIK3CA', 'PRKCB', 'PRKCE', 'PIK3CD', 'PRKCQ', 'PIK3CB', 'NFKB1', 'PDK1']",0.005974683699456865,0,0,9
12,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.00023308233463310222,3.9312638580931263,32.88155794046229,"['ITGB1', 'RYR2', 'CACNG7', 'LAMA2', 'ITGA2B', 'CACNA2D3', 'ITGA8', 'ITGAV', 'CACNA1D', 'CACNA1C', 'SLC8A1', 'ITGA9']",0.008895975771830067,0,0,12
13,Integrin-mediated Cell Adhesion WP185,0.00043229753379091696,3.056288271314178,23.675220679763722,"['VASP', 'ITGB1', 'VAV3', 'ITGA2B', 'PXN', 'BRAF', 'PTK2', 'MAPK10', 'RAP1A', 'CAPN7', 'AKT3', 'ITGA8', 'ITGAV', 'SOS1', 'ITGA9']",0.015230174652018461,0,0,15
14,Regulation of Actin Cytoskeleton WP51,0.0007080756407813748,2.5084062761420904,18.19336946330859,"['PDGFRB', 'EGF', 'PXN', 'PIK3R3', 'PIK3CD', 'BRAF', 'PIK3CB', 'ARHGAP35', 'PTK2', 'ENAH', 'GNA13', 'FGF14', 'PIK3CA', 'APC', 'PIP5K1B', 'SOS1', 'FGF12', 'SOS2', 'ARHGEF6']",0.02285355149930976,0,0,19
15,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.0007484787608944244,3.1746545078499575,22.849473374357792,"['GSK3B', 'ITPR2', 'TBC1D4', 'PIK3CA', 'NPY', 'AKT3', 'ZNF516', 'ITGAV', 'PRKCQ', 'PPARG', 'SOS1', 'MAP4K5', 'PPARGC1A']",0.02285355149930976,0,0,13
16,miRNA regulation of prostate cancer signaling pathways WP3981,0.0008096785614693202,4.871305649083427,34.67820736458043,"['PDGFRB', 'NFKBIA', 'GSK3B', 'CREBBP', 'PIK3CA', 'AKT3', 'SOS1', 'NFKB1']",0.02306290575124201,0,0,8
17,Ras signaling WP4223,0.0008560467200242668,2.3385413524763226,16.517551614805424,"['PDGFRB', 'KSR1', 'PRKCB', 'GAB1', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'RASGRP2', 'STK4', 'NFKB1', 'IGF1R', 'MAPK10', 'AFDN', 'RAP1A', 'PIK3CA', 'AKT3', 'ABL2', 'RGL1', 'SOS1', 'RAPGEF5', 'SOS2']",0.02306290575124201,0,0,21
18,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.0009328108278197118,2.5988270556027566,18.132817155389773,"['MAP2K4', 'GSK3B', 'WNT5A', 'FZD6', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'HIF1A', 'PKD1', 'TJP1', 'ZEB1', 'FMNL2', 'PIK3CA', 'MMP15', 'AKT3', 'SOS1', 'SOS2']",0.023734853285634887,0,0,17
19,Hippo-Merlin Signaling Dysregulation WP4541,0.001187481943196011,2.849582784365393,19.19456231828462,"['PDGFRB', 'ITGB1', 'ITGA2B', 'PTK2', 'IGF1R', 'CDH7', 'PLCB4', 'PRKAR2B', 'ITGA8', 'ITGAV', 'NF2', 'TEAD1', 'CDH18', 'ITGA9']",0.02652118361152313,0,0,14
20,Prolactin Signaling Pathway WP2037,0.0012224191687119847,3.157997083130773,21.180444718611447,"['ITGB1', 'SOCS2', 'NFKBIA', 'GSK3B', 'PIK3CA', 'RPS6KA2', 'PXN', 'PIK3CB', 'JAK2', 'SOS1', 'PTK2', 'NFKB1']",0.02652118361152313,0,0,12
21,Resistin as a regulator of inflammation WP4481,0.001254351244047197,5.205835331734613,34.78089789022553,"['NFKBIA', 'PLCB4', 'PIK3CA', 'AKT3', 'PIK3CD', 'PIK3CB', 'NFKB1']",0.02652118361152313,0,0,7
22,MET in type 1 papillary renal cell carcinoma WP4205,0.0012739433175840806,3.3537151702786376,22.354651999605267,"['RAP1A', 'PIK3CA', 'AKT3', 'GAB1', 'PIK3CD', 'PIK3R3', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2', 'PTK2']",0.02652118361152313,0,0,11
23,Toll-like Receptor Signaling Pathway WP75,0.0014871364327121214,3.2789359018461184,21.348833158799867,"['NFKBIA', 'MAPK10', 'MAP2K4', 'PIK3CA', 'TRAF3', 'AKT3', 'PIK3R3', 'PIK3CD', 'MAP3K8', 'PIK3CB', 'NFKB1']",0.029613412442702245,0,0,11
24,Nanoparticle-mediated activation of receptor signaling WP2643,0.0016142242663367717,4.9314653540325635,31.703901402619238,"['ITGB1', 'MAPK10', 'PXN', 'AKT3', 'PIK3CD', 'SOS1', 'PTK2']",0.030804779749260058,0,0,7
25,Endometrial cancer WP4155,0.0017286697974308114,3.2074079059541436,20.40040709000678,"['GSK3B', 'PIK3CA', 'APC', 'EGF', 'AKT3', 'PIK3CD', 'PIK3R3', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2']",0.031669230688932466,0,0,11
26,Alpha 6 Beta 4 signaling pathway WP244,0.0020495382491265168,4.684532374100719,28.997914769528357,"['LAMA5', 'LAMA2', 'LAMA3', 'GAB1', 'LAMC1', 'SOS1', 'PTK2']",0.03610340454230557,0,0,7
27,Cancer immunotherapy by CTLA4 blockade WP4582,0.002247026400865334,10.686885245901639,65.17020293477066,"['PIK3CA', 'PIK3CD', 'PIK3R3', 'PIK3CB']",0.038116225614678624,0,0,4
28,Fatty Acid Biosynthesis WP357,0.002502743590597001,5.350308008213553,32.050312344932536,"['ACSS2', 'SCD', 'ACSL6', 'ACSL4', 'ACACB', 'ACACA']",0.0409377344461938,0,0,6
29,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.002742480960355055,6.683589743589744,39.42577613016178,"['TJP1', 'PXN', 'ITGAV', 'PRKCQ', 'PTK2']",0.04192748711271004,0,0,5
30,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.002746341950614195,2.8242714223575467,16.65609962749497,"['GSK3B', 'MAP2K4', 'PIK3CA', 'PRKCB', 'EGF', 'WNT5A', 'PIK3CD', 'PIK3R3', 'NRG1', 'PIK3CB', 'NFKB1', 'IGF1R']",0.04192748711271004,0,0,12
31,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.002939667881195928,3.444813888480212,20.08140018733278,"['MAPK10', 'MAP2K4', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PIK3R3', 'PIK3CB', 'EIF4G3', 'PDK1']",0.043431222244765644,0,0,9
32,Regulation of toll-like receptor signaling pathway WP1449,0.003093045082848214,2.6433048165209487,15.27459912352779,"['MAP2K4', 'PELI2', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TRAF3', 'AKT3', 'TIFA', 'MAP3K8']",0.04426920774826506,0,0,13
33,Ciliopathies WP4803,0.00355348050524647,2.0477626150428434,11.549028384428,"['INVS', 'DNAH11', 'C2CD3', 'WDR19', 'SCLT1', 'PKD2', 'PKD1', 'TTBK2', 'PKHD1', 'AHI1', 'TTLL5', 'NME7', 'KIAA0586', 'CSPP1', 'TTC21B', 'SPAG1', 'NEK1', 'BBS9', 'RAB28', 'CCDC151', 'KIZ']",0.049228674158582765,0,0,21
34,Gastrin signaling pathway WP4659,0.0037212050423733743,2.4727307398932115,13.831733046608196,"['ITGB1', 'GSK3B', 'PRKCE', 'PXN', 'PIK3R3', 'PTK2', 'NFKB1', 'NFKBIA', 'TJP1', 'PIK3CA', 'PRKCQ', 'PPARG', 'JAK2', 'SOS1']",0.049228674158582765,0,0,14
35,Microglia Pathogen Phagocytosis Pathway WP3937,0.0037620165841711723,6.0755244755244755,33.91843889115872,"['VAV3', 'PIK3CA', 'PIK3R3', 'PIK3CD', 'PIK3CB']",0.049228674158582765,0,0,5
36,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.005026775189170948,5.568803418803419,29.4755462745259,"['PYGO1', 'GSK3B', 'APC', 'ZBTB16', 'FZD6']",0.06395175101778594,0,0,5
37,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.005717710097249242,3.3464506172839505,17.281696393741786,"['NFKBIA', 'GSK3B', 'PIK3CA', 'MAP3K8', 'PRKCQ', 'SOS1', 'NFKB1', 'PDK1']",0.06720974811105358,0,0,8
38,G13 Signaling Pathway WP524,0.005723100821683602,3.7461870503597123,19.342479754100147,"['GNA13', 'MAPK10', 'CYFIP1', 'PIK3CA', 'PIK3CD', 'PIK3CB', 'CIT']",0.06720974811105358,0,0,7
39,Signaling of Hepatocyte Growth Factor Receptor WP313,0.005723100821683602,3.7461870503597123,19.342479754100147,"['ITGB1', 'RAP1A', 'PIK3CA', 'PXN', 'GAB1', 'SOS1', 'PTK2']",0.06720974811105358,0,0,7
40,DNA damage response (only ATM dependent) WP710,0.005886028277202659,2.4219091118005287,12.436924277535509,"['GSK3B', 'WNT5A', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'NFKB1', 'MAPK10', 'PIK3CA', 'APC', 'AKT3', 'SOS1', 'SOS2', 'PDK1']",0.06739502377397044,0,0,13
41,"Relationship between inflammation, COX-2 and EGFR WP4483",0.006565557971592858,5.1400394477317555,25.833415665543473,"['PIK3CA', 'AKT3', 'PIK3CD', 'BRAF', 'PIK3CB']",0.07280085562072017,0,0,5
42,Insulin Signaling WP481,0.0068005149069185625,1.994870252341311,9.95591257235288,"['MAP2K4', 'GSK3B', 'PRKCB', 'GAB1', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'IGF1R', 'GYS2', 'MAPK10', 'TBC1D4', 'PIK3CA', 'RPS6KA2', 'MAP3K8', 'PRKCQ', 'SOS1', 'MAP4K5', 'SOS2', 'MAP4K3']",0.07280085562072017,0,0,19
43,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.006835014829019579,3.6018262313226344,17.957612936622063,"['ITGB1', 'GSK3B', 'RICTOR', 'PPARGC1A', 'NFKB1', 'IGF1R', 'PDK1']",0.07280085562072017,0,0,7
44,ESC Pluripotency Pathways WP3931,0.007170559035834729,2.356088767153917,11.63382833977359,"['PDGFRB', 'GSK3B', 'EGF', 'WNT5A', 'FZD6', 'GAB1', 'PIK3CD', 'BRAF', 'FGF14', 'APC', 'AKT3', 'SOS1', 'FGF12']",0.07463900087300696,0,0,13
45,Overview of nanoparticle effects WP3287,0.007452873109940094,6.677766393442623,32.71541707998406,"['LAMA3', 'AKT3', 'PIK3CD', 'PTK2']",0.07585368631894585,0,0,4
46,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.008406260086277793,4.7725274725274724,22.80685216472793,"['ITGB1', 'LAMA5', 'EDA', 'WNT5A', 'NFKB1']",0.08369711129380933,0,0,5
47,Mesodermal commitment pathway WP2857,0.008754295054641453,2.209377664109122,10.468497188144907,"['VAV3', 'MACF1', 'ARID5B', 'ACACA', 'CCDC88A', 'AEBP2', 'TRIM5', 'SESN1', 'CCDC6', 'RARB', 'ASCC3', 'JAK2', 'JARID2', 'TEAD1']",0.08530781138352736,0,0,14
48,IL-6 signaling pathway WP364,0.009528156693980827,3.3440390544707093,15.561499120925857,"['NCOA1', 'GSK3B', 'MAP2K4', 'CREBBP', 'GAB1', 'JAK2', 'SOS1']",0.08640696331075447,0,0,7
49,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.009532982293359726,3.8198885303608097,17.773932442419362,"['GSK3B', 'PIK3CA', 'PIK3R3', 'RICTOR', 'PIK3CB', 'PDK1']",0.08640696331075447,0,0,6
50,Prostaglandin Synthesis and Regulation WP98,0.009532982293359726,3.8198885303608097,17.773932442419362,"['HSD11B2', 'ANXA4', 'ANXA5', 'MITF', 'PPARG', 'PPARGC1A']",0.08640696331075447,0,0,6
51,HIF1A and PPARG regulation of glycolysis WP2456,0.009621736089188817,10.009467758444217,46.48127135860962,"['GPAT3', 'PPARG', 'HIF1A']",0.08640696331075447,0,0,3
52,miRNA targets in ECM and membrane receptors WP2911,0.010177730962469333,5.935336976320583,27.228674046243537,"['LAMA4', 'COL6A1', 'COL5A2', 'LAMC1']",0.08831083838110144,0,0,4
53,Genes controlling nephrogenesis WP4823,0.010575488099684218,4.454017094017094,20.26228760604753,"['RET', 'ITGB1', 'PDGFRB', 'ITGA8', 'SLIT2']",0.08831083838110144,0,0,5
54,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.010575488099684218,4.454017094017094,20.26228760604753,"['NFKBIA', 'GSK3B', 'DYRK1A', 'NFKB1', 'PDK1']",0.08831083838110144,0,0,5
55,MAPK Signaling Pathway WP382,0.010605013342708688,1.7775075367227566,8.08131080449689,"['PDGFRB', 'MAP2K4', 'DUSP1', 'EGF', 'CACNA2D3', 'BRAF', 'CACNA1D', 'CACNA1C', 'RASGRP2', 'STK4', 'NFKB1', 'MAPK10', 'CACNG7', 'RAP1A', 'FGF14', 'TAOK3', 'AKT3', 'RAPGEF2', 'MAP3K8', 'SOS1', 'FGF12', 'SOS2', 'MAP4K3']",0.08831083838110144,0,0,23
56,Pathways in clear cell renal cell carcinoma WP4018,0.010917315999531082,2.415909590756061,10.913642370356971,"['PDGFRB', 'PBRM1', 'CREBBP', 'ZEB1', 'KSR1', 'ME1', 'PLOD2', 'RAPGEF5', 'HIF1A', 'ACACB', 'ACACA']",0.08928804871045064,0,0,11
57,PDGFR-beta pathway WP3972,0.011431894593379462,3.6459772260593617,16.30243319184242,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'PRKCB', 'JAK2', 'SOS1']",0.09185627585557532,0,0,6
58,Pathways Regulating Hippo Signaling WP4540,0.01206769339414648,2.3767602117247577,10.498680739105414,"['PDGFRB', 'PLCB4', 'PRKCB', 'PRKAR2B', 'PRKCE', 'PRKCQ', 'NF2', 'TEAD1', 'CDH18', 'IGF1R', 'CDH7']",0.0952931650779153,0,0,11
59,Oncostatin M Signaling Pathway WP2374,0.013277795553141217,2.618837594590964,11.317731299634763,"['NFKBIA', 'PRKCB', 'PRKCE', 'PXN', 'RICTOR', 'JAK2', 'SOS1', 'HIF1A', 'NFKB1']",0.10116000422957483,0,0,9
60,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.013410694373821442,2.8167641325536064,12.145049804958523,"['GSK3B', 'PIK3CA', 'HOMER1', 'AKT3', 'PIK3CD', 'PIK3R3', 'PIK3CB', 'CACNA1C']",0.10116000422957483,0,0,8
61,MAPK pathway in congenital thyroid cancer WP4928,0.013473275672497958,5.341393442622951,23.005633325615488,"['KSR1', 'BRAF', 'SOS1', 'SOS2']",0.10116000422957483,0,0,4
62,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.013971728110255245,2.0118652849740934,8.592112126550255,"['MAP2K4', 'GSK3B', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'MAPK10', 'PIK3CA', 'SCD', 'RPS6KA2', 'MAP3K8', 'RICTOR', 'SOS1', 'MAP4K5', 'SOS2', 'MAP4K3']",0.10157224562693495,0,0,15
63,Hepatitis B infection WP4666,0.013971728110255245,2.0118652849740934,8.592112126550255,"['MAP2K4', 'CREBBP', 'PRKCB', 'PIK3R3', 'PIK3CD', 'BRAF', 'PIK3CB', 'NFKB1', 'MAPK10', 'PIK3CA', 'TRAF3', 'AKT3', 'JAK2', 'SOS1', 'SOS2']",0.10157224562693495,0,0,15
64,Wnt signaling pathway and pluripotency WP399,0.0146426457198777,2.3021317079463364,9.72378320128133,"['MAPK10', 'MAP2K4', 'GSK3B', 'CREBBP', 'APC', 'PRKCB', 'PRKCE', 'WNT5A', 'FZD6', 'ESRRB', 'PRKCQ']",0.10478643343287479,0,0,11
65,Rett syndrome causing genes WP4312,0.015201034210268973,2.7443283739580036,11.488833837731674,"['CDKL5', 'TRRAP', 'SCN8A', 'GABRA3', 'BRAF', 'HIVEP2', 'HAP1', 'SCN1A']",0.10710882566620292,0,0,8
66,MAPK Cascade WP422,0.0160007649446051,3.3416324435318274,13.818046969005051,"['MAPK10', 'MAP2K4', 'MAP2', 'BRAF', 'SOS1', 'SOS2']",0.10827356680060364,0,0,6
67,Neural Crest Cell Migration during Development WP4564,0.0160007649446051,3.3416324435318274,13.818046969005051,"['TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'PIK3CB']",0.10827356680060364,0,0,6
68,Glioblastoma signaling pathways WP2261,0.01607555140270971,2.2665396522981665,9.36184164326291,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'PRKCB', 'AKT3', 'GAB1', 'PIK3CD', 'PRKCQ', 'BRAF', 'PIK3CB', 'IGF1R']",0.10827356680060364,0,0,11
69,Breast cancer pathway WP4262,0.01806873004786163,1.99645390070922,8.012912386428335,"['NCOA1', 'GSK3B', 'EGF', 'WNT5A', 'FZD6', 'PIK3R3', 'PIK3CD', 'BRAF', 'IGF1R', 'PIK3CA', 'APC', 'AKT3', 'SOS1', 'SOS2']",0.11993446901334241,0,0,14
70,15q13.3 copy number variation syndrome WP4942,0.020779602730812016,6.671954964176049,25.845708461543204,"['KAT2B', 'MTMR10', 'CREBBP']",0.1321813618154431,0,0,3
71,Biotin Metabolism (including IEMs) WP5031,0.020779602730812016,6.671954964176049,25.845708461543204,"['PCCA', 'ACACB', 'ACACA']",0.1321813618154431,0,0,3
72,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.020779602730812016,6.671954964176049,25.845708461543204,"['PRKCQ', 'ITGAV', 'PTK2']",0.1321813618154431,0,0,3
73,Disruption of postsynaptic signaling by CNV WP4875,0.021695212795785387,3.0841099352392987,11.814187825418749,"['TJP1', 'RYR2', 'CYFIP1', 'NLGN4X', 'HOMER1', 'NRXN1']",0.13611517069136586,0,0,6
74,Head and Neck Squamous Cell Carcinoma WP4674,0.022659853263911657,2.3611801054098263,8.94216802613541,"['PIK3CA', 'TRAF3', 'SESN1', 'AKT3', 'GAB1', 'RICTOR', 'PIK3CB', 'NFKB1', 'IGF1R']",0.1383761705982872,0,0,9
75,Melanoma WP4685,0.022659853263911657,2.3611801054098263,8.94216802613541,"['PIK3CA', 'AKT3', 'PIK3CD', 'PIK3R3', 'MITF', 'BRAF', 'PIK3CB', 'SOS1', 'SOS2']",0.1383761705982872,0,0,9
76,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.024997483866955564,2.9696554871092857,10.955000009167769,"['ITGB1', 'MAPK10', 'NF2', 'MAP4K5', 'TEAD1', 'MAP4K3']",0.14776172934969528,0,0,6
77,Neural Crest Cell Migration in Cancer WP4565,0.024997483866955564,2.9696554871092857,10.955000009167769,"['TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'PIK3CB']",0.14776172934969528,0,0,6
78,Corticotropin-releasing hormone signaling pathway WP2355,0.02516466133029745,2.1940172384654386,8.079061702853837,"['NFKBIA', 'GSK3B', 'NCOA2', 'GRK3', 'PRKCB', 'PRKCQ', 'BRAF', 'ACACA', 'PTK2', 'NFKB1']",0.14776172934969528,0,0,10
79,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.026624034209133365,13.33435582822086,48.34958656534051,"['TRAF3', 'NFKB1']",0.15165756990786758,0,0,2
80,FTO Obesity Variant Mechanism WP3407,0.026624034209133365,13.33435582822086,48.34958656534051,"['ARID5B', 'PPARGC1A']",0.15165756990786758,0,0,2
81,Hippo-Yap signaling pathway WP4537,0.027109022374805485,4.107818411097099,14.820551534809834,"['NF2', 'TNIK', 'TEAD1', 'MAP4K3']",0.15165756990786758,0,0,4
82,IL17 signaling pathway WP2112,0.027152665354683716,3.3392307692307694,12.042201358775513,"['GSK3B', 'PIK3CA', 'TRAF3', 'JAK2', 'NFKB1']",0.15165756990786758,0,0,5
83,TCA cycle in senescence WP5050,0.028168432509822722,5.718379880099429,20.41206201524145,"['ME1', 'BRAF', 'PDK1']",0.1554354468614314,0,0,3
84,Nephrotic syndrome WP4758,0.028618484651066957,2.8633763567028456,10.175587583988523,"['CUBN', 'ANLN', 'TRPC6', 'TTC21B', 'PDSS2', 'ARHGAP24']",0.15603888059748414,0,0,6
85,Osteoblast differentiation WP4787,0.029199289386985502,2.0450779727095516,7.226509828122161,"['MAPK10', 'PIK3CA', 'PRKCB', 'PRKCE', 'WNT5A', 'FZD6', 'PIK3R3', 'PIK3CD', 'PRKCQ', 'PPARG', 'PIK3CB']",0.15733264163811014,0,0,11
86,Vitamin D in inflammatory diseases WP4482,0.032978592938012884,3.814110070257611,13.013349283184267,"['NFKBIA', 'DUSP1', 'NR3C1', 'NFKB1']",0.17563018099546396,0,0,4
87,GDNF/RET signaling axis WP4830,0.03676052988705917,5.003198567041966,16.527218758406974,"['RET', 'GFRA1', 'SLIT2']",0.18707025209192332,0,0,3
88,Leptin Insulin Overlap WP3935,0.03676052988705917,5.003198567041966,16.527218758406974,"['SOCS2', 'PIK3R3', 'JAK2']",0.18707025209192332,0,0,3
89,"NAD metabolism, sirtuins and aging WP3630",0.03676052988705917,5.003198567041966,16.527218758406974,"['PPARG', 'HIF1A', 'NFKB1']",0.18707025209192332,0,0,3
90,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.03676052988705917,5.003198567041966,16.527218758406974,"['ZEB1', 'JAK2', 'NFKB1']",0.18707025209192332,0,0,3
91,Ectoderm Differentiation WP2858,0.03790015557935018,1.8322973929135145,5.9967430209578,"['EDA', 'ELOVL4', 'ZBTB16', 'SOCS2', 'AHI1', 'ARHGAP10', 'PLCXD3', 'GLB1', 'NARS2', 'NF2', 'ZBTB7B', 'ANKS1B', 'CDON']",0.18992934093634412,0,0,13
92,Wnt signaling WP428,0.03815174534092502,2.027022805373321,6.620628994134944,"['INVS', 'GSK3B', 'PLCB4', 'APC', 'PRKCB', 'WNT5A', 'FZD6', 'PRICKLE2', 'CXXC4', 'DKK2']",0.18992934093634412,0,0,10
93,Angiogenesis WP1539,0.03953122428903204,3.5595628415300546,11.499753062099106,"['CREBBP', 'PIK3CA', 'HIF1A', 'PTK2']",0.19260958217421995,0,0,4
94,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.03953122428903204,3.5595628415300546,11.499753062099106,"['HIF1A', 'ACACB', 'ACACA', 'PDK1']",0.19260958217421995,0,0,4
95,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.04233507043494024,8.88888888888889,28.10790620566486,"['PPARG', 'CYP2C18']",0.20341547752224728,0,0,2
96,Leptin signaling pathway WP2034,0.04263730533217411,2.0750914450087006,6.546966832411531,"['NCOA1', 'SOCS2', 'GSK3B', 'JAK2', 'SOS1', 'ACACB', 'ACACA', 'PTK2', 'NFKB1']",0.20341547752224728,0,0,9
97,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.04652976364613488,4.446946434663937,13.641733453010907,"['GSK3B', 'APC', 'TNKS']",0.21637107770015432,0,0,3
98,EPO Receptor Signaling WP581,0.04677016745047004,3.3368340163934427,10.219086632436547,"['PTPRU', 'JAK2', 'SOS1', 'PDK1']",0.21637107770015432,0,0,4
99,NRF2-ARE regulation WP4357,0.04677016745047004,3.3368340163934427,10.219086632436547,"['GSK3B', 'MAF', 'PIK3CA', 'GCLM']",0.21637107770015432,0,0,4
100,AMP-activated protein kinase (AMPK) signaling WP1403,0.047472525379000326,2.1387654320987655,6.518110403234435,"['GYS2', 'PIK3CA', 'PIK3CD', 'PIK3R3', 'PIK3CB', 'CPT1B', 'ACACB', 'ACACA']",0.2174241662358215,0,0,8
101,Pancreatic adenocarcinoma pathway WP4263,0.05141259817570038,1.9106038291605303,5.6704276761701395,"['MAPK10', 'PIK3CA', 'EGF', 'AKT3', 'PIK3CD', 'PIK3R3', 'BRAF', 'PIK3CB', 'NFKB1', 'ARHGEF6']",0.23262843347172962,0,0,10
102,Regulation of Microtubule Cytoskeleton WP2038,0.05180807907012319,2.4285980959492255,7.189158366680725,"['GSK3B', 'CLIP1', 'TRIO', 'APC', 'PIK3CA', 'MARK1']",0.23262843347172962,0,0,6
103,Phytochemical activity on NRF2 transcriptional activation WP3,0.057435387547876984,4.001944728761515,11.433934905422408,"['MAF', 'PIK3CA', 'GCLM']",0.25350741016634654,0,0,3
104,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.057565001435152925,2.1750041827003512,6.20929005003039,"['GSK3B', 'MAP2K4', 'APC', 'FZD6', 'SOS1', 'NEFH', 'PTK2']",0.25350741016634654,0,0,7
105,Pilocytic astrocytoma WP2253,0.06060373064287317,6.666155419222904,18.68789227643722,"['BRAF', 'SOS1']",0.26059248235917426,0,0,2
106,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.06060373064287317,6.666155419222904,18.68789227643722,"['NFKBIA', 'NFKB1']",0.26059248235917426,0,0,2
107,Apoptosis WP254,0.06088077644635731,2.017237363149313,5.645920207341775,"['NFKBIA', 'MAPK10', 'MAP2K4', 'CRADD', 'CASP6', 'TRAF3', 'NFKB1', 'IGF1R']",0.26059248235917426,0,0,8
108,BDNF-TrkB Signaling WP3676,0.061677853152581036,2.567455621301775,7.152495808915049,"['TRPC6', 'HOMER1', 'GAB1', 'BRAF', 'SOS1']",0.2615597846655751,0,0,5
109,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.06329197958554557,2.9656193078324224,8.185099392365558,"['TGFBR3', 'APC', 'WNT5A', 'MFGE8']",0.2646472873352279,0,0,4
110,PPAR signaling pathway WP3942,0.06356157556086259,2.2894690525080668,6.309195524843502,"['SCD', 'ME1', 'ACSL6', 'ACSL4', 'PPARG', 'CPT1B']",0.2646472873352279,0,0,6
111,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.06997918656066657,2.225701574264203,5.919381127622031,"['GSK3B', 'KAT2B', 'CREBBP', 'APC', 'CTSK', 'PPARG']",0.2887429499530206,0,0,6
112,Wnt signaling in kidney disease WP4150,0.07255463466902835,2.809318377911993,7.370009150280478,"['INVS', 'MAPK10', 'WNT5A', 'FZD6']",0.29669663105727667,0,0,4
113,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.07695430195515492,2.3836996336996337,6.113101435905783,"['PIK3CA', 'GABRA3', 'PIK3R3', 'PIK3CB', 'JAK2']",0.3065819997439446,0,0,5
114,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.0805942374504696,1.9892851676105925,5.009672791564872,"['ITGB1', 'NFKBIA', 'PIK3CA', 'PXN', 'SOS1', 'PTK2', 'NFKB1']",0.3065819997439446,0,0,7
115,Regulatory circuits of the STAT3 signaling pathway WP4538,0.0805942374504696,1.9892851676105925,5.009672791564872,"['PTPRT', 'PDGFRB', 'MAPK10', 'CREBBP', 'PRKCB', 'RICTOR', 'JAK2']",0.3065819997439446,0,0,7
116,Aspirin and miRNAs WP4707,0.08099655451750502,5.332515337423313,13.402470288595813,"['NFKB1', 'PDK1']",0.3065819997439446,0,0,2
117,Inflammatory Response Pathway WP453,0.08099655451750502,5.332515337423313,13.402470288595813,"['LAMA5', 'LAMC1']",0.3065819997439446,0,0,2
118,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.08099655451750502,5.332515337423313,13.402470288595813,"['ITGB1', 'NRG3']",0.3065819997439446,0,0,2
119,Osteoblast Signaling WP322,0.08099655451750502,5.332515337423313,13.402470288595813,"['PDGFRB', 'ITGAV']",0.3065819997439446,0,0,2
120,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.08099655451750502,5.332515337423313,13.402470288595813,"['TIFA', 'NFKB1']",0.3065819997439446,0,0,2
121,Supression of HMGB1 mediated inflammation by THBD WP4479,0.08099655451750502,5.332515337423313,13.402470288595813,"['NFKBIA', 'NFKB1']",0.3065819997439446,0,0,2
122,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.08211771579459713,1.8750992708107719,4.6870009549855824,"['CDK8', 'SEC24B', 'PIK3CA', 'SCD', 'PPARG', 'SEC24D', 'LSS', 'ACACA']",0.3070614080607276,0,0,8
123,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.08246408993770633,2.6686475409836063,6.659322668978761,"['FGD4', 'MTMR2', 'SBF2', 'GDAP1']",0.3070614080607276,0,0,4
124,IL-4 signaling pathway WP395,0.08389133106607394,2.108235166972874,5.224697952954238,"['NFKBIA', 'PIK3CA', 'PIK3CD', 'JAK2', 'SOS1', 'NFKB1']",0.30985669055049886,0,0,6
125,RANKL/RANK signaling pathway WP2018,0.09137998626882221,2.054019902069183,4.91471256130522,"['NFKBIA', 'TRAF3', 'CTSK', 'MITF', 'PTK2', 'NFKB1']",0.3348162696889646,0,0,6
126,Endoderm differentiation WP2853,0.09416636515542091,1.633791996330696,3.86014763712674,"['VAV3', 'AEBP2', 'APC', 'RFX7', 'TRIM5', 'SESN1', 'LAMC1', 'ASCC3', 'NR3C1', 'JARID2', 'ACACA']",0.34227390030577054,0,0,11
127,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.09640465750970392,3.0777104165026374,7.1993825580129736,"['AEBP2', 'STK38', 'JARID2']",0.34227390030577054,0,0,3
128,Pregnane X receptor pathway WP2876,0.09640465750970392,3.0777104165026374,7.1993825580129736,"['NCOA1', 'NCOA2', 'PPARGC1A']",0.34227390030577054,0,0,3
129,Transcription factor regulation in adipogenesis WP3599,0.09640465750970392,3.0777104165026374,7.1993825580129736,"['PPARG', 'NR3C1', 'PPARGC1A']",0.34227390030577054,0,0,3
130,EGF/EGFR signaling pathway WP437,0.09768242309937393,1.4974479931946485,3.483114410787707,"['VAV3', 'PRKCB', 'EGF', 'GAB1', 'BRAF', 'PTPN12', 'PTK2', 'ATXN2', 'RAP1A', 'RPS6KA2', 'RICTOR', 'JAK2', 'SOS1', 'SOS2', 'SH3GL2']",0.3431277864976137,0,0,15
131,Ebola Virus Pathway on Host WP4217,0.10237981872683587,1.649739086165203,3.759863713337284,"['ITGB1', 'CREBBP', 'PIK3CA', 'PIK3R3', 'PIK3CD', 'ITGAV', 'PIK3CB', 'MFGE8', 'NFKB1', 'IGF1R']",0.3431277864976137,0,0,10
132,Canonical NF-KB pathway WP4562,0.1031280720628048,4.443421949556919,10.094493313153222,"['NFKBIA', 'NFKB1']",0.3431277864976137,0,0,2
133,Farnesoid X receptor pathway WP2879,0.1031280720628048,4.443421949556919,10.094493313153222,"['PPARGC1A', 'FKBP5']",0.3431277864976137,0,0,2
134,IL1 and megakaryocytes in obesity WP2865,0.1031280720628048,4.443421949556919,10.094493313153222,"['PIK3CA', 'NFKB1']",0.3431277864976137,0,0,2
135,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.1031280720628048,4.443421949556919,10.094493313153222,"['TIFA', 'NFKB1']",0.3431277864976137,0,0,2
136,Complement system WP2806,0.10330364931941267,2.152522746071133,4.88640438049411,"['LAMA5', 'PROS1', 'ITGA2B', 'LAMC1', 'KLKB1']",0.3431277864976137,0,0,5
137,Glycerophospholipid Biosynthetic Pathway WP2533,0.10413703564010547,2.4256706408345754,5.486982443715039,"['PIK3CA', 'PIK3CD', 'GPAT3', 'PIK3CB']",0.3431277864976137,0,0,4
138,Lipid Metabolism Pathway WP3965,0.10413703564010547,2.4256706408345754,5.486982443715039,"['ACSS2', 'PRKAR2B', 'AKT3', 'ACACA']",0.3431277864976137,0,0,4
139,Nuclear receptors WP170,0.10413703564010547,2.4256706408345754,5.486982443715039,"['ESRRB', 'RARB', 'PPARG', 'NR3C1']",0.3431277864976137,0,0,4
140,Constitutive Androstane Receptor Pathway WP2875,0.11125373212532008,2.8576546278695716,6.275243279606862,"['NCOA1', 'NCOA2', 'PPARGC1A']",0.36395863795283284,0,0,3
141,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.11583641059999678,1.797315993359159,3.8742518247988134,"['GSK3B', 'CDK8', 'APC', 'WNT5A', 'FZD6', 'CXXC4', 'DKK2']",0.37626295074325194,0,0,7
142,Thermogenesis WP4321,0.12006425687577105,1.5904516445753558,3.3713252105703333,"['ADCY9', 'RPS6KA2', 'ZNF516', 'ACSL6', 'ACSL4', 'PPARG', 'SOS1', 'CPT1B', 'PPARGC1A', 'SOS2']",0.3860057361713506,0,0,10
143,PDGF Pathway WP2526,0.12303707303349175,2.0217560217560218,4.236123854675504,"['PDGFRB', 'NFKBIA', 'MAP2K4', 'SOS1', 'NFKB1']",0.3860057361713506,0,0,5
144,TGF-beta Receptor Signaling WP560,0.12303707303349175,2.0217560217560218,4.236123854675504,"['TGFBR3', 'CREBBP', 'EGF', 'LTBP1', 'NFKB1']",0.3860057361713506,0,0,5
145,Glutathione metabolism WP100,0.12665622376478813,3.808355243938066,7.869123559807661,"['IDH1', 'GCLM']",0.3860057361713506,0,0,2
146,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.12679911973959188,1.472534310202794,3.041005967009796,"['VAV3', 'CYFIP1', 'GSK3B', 'CDKL5', 'KSR1', 'ACACB', 'NFKB1', 'NFKBIA', 'MAPK10', 'GRIP1', 'RAP1A', 'APC', 'JAK2']",0.3860057361713506,0,0,13
147,Apoptosis Modulation by HSP70 WP384,0.1269087687168096,2.666939611054248,5.505328254767208,"['MAPK10', 'CASP6', 'NFKB1']",0.3860057361713506,0,0,3
148,Globo Sphingolipid Metabolism WP1424,0.1269087687168096,2.666939611054248,5.505328254767208,"['ST8SIA1', 'B3GALT5', 'ST6GALNAC3']",0.3860057361713506,0,0,3
149,miRNAs involvement in the immune response in sepsis WP4329,0.1269087687168096,2.666939611054248,5.505328254767208,"['NFKBIA', 'TRAF3', 'NFKB1']",0.3860057361713506,0,0,3
150,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.1269087687168096,2.666939611054248,5.505328254767208,"['RAP1A', 'BRAF', 'NR3C1']",0.3860057361713506,0,0,3
151,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.12810670720097225,2.2231898907103824,4.5684144813968235,"['NFKBIA', 'CREBBP', 'NELFA', 'NFKB1']",0.3860057361713506,0,0,4
152,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.12810670720097225,2.2231898907103824,4.5684144813968235,"['SEC16B', 'PIK3CA', 'BRAF', 'PRKCQ']",0.3860057361713506,0,0,4
153,MED and Pseudoachondroplasia genes WP4789,0.1348907493573707,13.321756894790603,26.68734359795222,['MATN1'],0.40116859224464796,0,0,1
154,Nanomaterial-induced inflammasome activation WP3890,0.1348907493573707,13.321756894790603,26.68734359795222,['NFKB1'],0.40116859224464796,0,0,1
155,B Cell Receptor Signaling Pathway WP23,0.13605341448079644,1.6433048433048434,3.277912852025055,"['NFKBIA', 'GSK3B', 'PRKCB', 'GAB1', 'PIP5K1B', 'BRAF', 'SOS1', 'NFKB1']",0.4020158956916437,0,0,8
156,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.14026605527165495,1.6988881621975147,3.3369803628976253,"['GNA13', 'RAP1A', 'PIK3CA', 'PDE4D', 'BRAF', 'JAK2', 'IGF1R']",0.41096786802691143,0,0,7
157,Melatonin metabolism and effects WP3298,0.140877631616212,2.1340983606557375,4.18254175197681,"['GSK3B', 'MAP2', 'CLOCK', 'NFKB1']",0.41096786802691143,0,0,4
158,TLR4 Signaling and Tolerance WP3851,0.1432920658711164,2.5000639713408392,4.857300070380251,"['NFKBIA', 'TRAF3', 'NFKB1']",0.4153656086643754,0,0,3
159,TGF-beta Signaling Pathway WP366,0.14574942904255275,1.4842334594656577,2.8584353064975154,"['ITGB1', 'TGFBR3', 'MAP2K4', 'CREBBP', 'RBL1', 'ZEB1', 'WWP1', 'NUP153', 'SOS1', 'PTK2', 'PDK1']",0.41983168868861104,0,0,11
160,Development and heterogeneity of the ILC family WP3893,0.15127818549281,3.332055214723926,6.29303559754161,"['IL15', 'ZBTB16']",0.4276877096031295,0,0,2
161,Dopaminergic Neurogenesis WP2855,0.15127818549281,3.332055214723926,6.29303559754161,"['RET', 'ALDH1A1']",0.4276877096031295,0,0,2
162,Osteopontin Signaling WP1434,0.15127818549281,3.332055214723926,6.29303559754161,"['ITGAV', 'NFKB1']",0.4276877096031295,0,0,2
163,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.15316232623614692,1.740514239800018,3.2656519637379393,"['GSK3B', 'APC', 'WNT5A', 'FZD6', 'CXXC4', 'DKK2']",0.427823782460142,0,0,6
164,Fatty acid beta-oxidation WP143,0.15412865525310793,2.051860025220681,3.8369117702202082,"['ACSS2', 'ACSL6', 'ACSL4', 'CPT1B']",0.427823782460142,0,0,4
165,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.15412865525310793,2.051860025220681,3.8369117702202082,"['NFKBIA', 'PIK3CA', 'JAK2', 'NFKB1']",0.427823782460142,0,0,4
166,Splicing factor NOVA regulated synaptic proteins WP4148,0.15559352341052407,1.8528490028490028,3.447240932568009,"['PLCB4', 'CADM1', 'EPB41', 'EFNA5', 'NEO1']",0.42928815495192785,0,0,5
167,1q21.1 copy number variation syndrome WP4905,0.1603253484603506,2.3528207598290085,4.306956278333424,"['TJP1', 'PYGO1', 'AFDN']",0.4396946682325783,0,0,3
168,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.16716303119446288,1.8026334026334025,3.2245248675295803,"['ELOVL4', 'SOAT1', 'SCD', 'ACSL4', 'LSS']",0.4521404939840518,0,0,5
169,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.16716303119446288,1.8026334026334025,3.2245248675295803,"['TGFBR3', 'CREBBP', 'EGF', 'LTBP1', 'NFKB1']",0.4521404939840518,0,0,5
170,Oxidative Damage WP3941,0.16782507418622009,1.9757134183363692,3.526318640184253,"['MAPK10', 'MAP2K4', 'TRAF3', 'NFKB1']",0.4521404939840518,0,0,4
171,Apoptosis Modulation and Signaling WP1772,0.17632428664079852,1.5832215583465432,2.747570888156089,"['NFKBIA', 'TNFRSF6B', 'CRADD', 'CASP6', 'TRAF3', 'BIRC6', 'NFKB1']",0.4631666862348455,0,0,7
172,GPR40 Pathway WP3958,0.17672656393868072,2.961599636446262,5.132901081543591,"['PLCL1', 'PKD1']",0.4631666862348455,0,0,2
173,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.17672656393868072,2.961599636446262,5.132901081543591,"['NFKBIA', 'NFKB1']",0.4631666862348455,0,0,2
174,RAS and bradykinin pathways in COVID-19 WP4969,0.17672656393868072,2.961599636446262,5.132901081543591,"['KLKB1', 'NFKB1']",0.4631666862348455,0,0,2
175,TNF-alpha signaling pathway WP231,0.17697417050458072,1.5253380364491476,2.641506411898039,"['NFKBIA', 'MAP2K4', 'CREBBP', 'KSR1', 'OTUD7B', 'MAP3K8', 'SOS1', 'NFKB1']",0.4631666862348455,0,0,8
176,Modulators of TCR signaling and T cell activation WP5072,0.1790586249329975,1.7550607287449393,3.0187781891062047,"['GNA13', 'NFKBIA', 'MAP3K8', 'PRKCQ', 'NFKB1']",0.46595937624609574,0,0,5
177,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.1819312234059246,1.9050058548009368,3.2463710678335014,"['NFKBIA', 'GSK3B', 'TRAF3', 'NFKB1']",0.4681151703365925,0,0,4
178,Vitamin D-sensitive calcium signaling in depression WP4698,0.1819312234059246,1.9050058548009368,3.2463710678335014,"['KCNQ3', 'ITPR2', 'CACNA1C', 'SLC8A1']",0.4681151703365925,0,0,4
179,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.1912595620263743,1.7099276791584483,2.828432087477109,"['NFKBIA', 'MAPK10', 'MAP2K4', 'MAP3K8', 'NFKB1']",0.4827014902277271,0,0,5
180,Adipogenesis WP236,0.19267710736394633,1.4472720955914284,2.3832801414958924,"['NCOA1', 'NCOA2', 'RBL1', 'SCD', 'SPOCK1', 'PPARG', 'NR3C1', 'HIF1A', 'PPARGC1A']",0.4827014902277271,0,0,9
181,Fragile X Syndrome  WP4549,0.19421163291167357,1.3854683879510097,2.2705150475173306,"['CYFIP1', 'GRIP1', 'HOMER1', 'KCNC1', 'KCND2', 'GAB1', 'BRAF', 'PIK3CB', 'SOS1', 'GRIP2', 'PDK1']",0.4827014902277271,0,0,11
182,Myometrial relaxation and contraction pathways WP289,0.19421163291167357,1.3854683879510097,2.2705150475173306,"['RYR2', 'ADCY9', 'PRKCB', 'PRKAR2B', 'PRKCE', 'PDE4D', 'ITPR2', 'PRKCQ', 'SLC8A1', 'NFKB1', 'CORIN']",0.4827014902277271,0,0,11
183,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.19535761552829228,6.660367722165475,10.875870800467789,['NRP1'],0.4827014902277271,0,0,1
184,Steroid Biosynthesis WP496,0.19535761552829228,6.660367722165475,10.875870800467789,['HSD17B4'],0.4827014902277271,0,0,1
185,Alzheimer's disease WP2059,0.19569835758328807,1.5310767779219248,2.497463039090355,"['GSK3B', 'PLCB4', 'EIF2AK3', 'ITPR2', 'CACNA1D', 'IDE', 'CACNA1C']",0.4827014902277271,0,0,7
186,Estrogen signaling pathway WP712,0.1960316095684656,2.1048321930722405,3.429780613709229,"['PIK3CA', 'BRAF', 'NFKB1']",0.4827014902277271,0,0,3
187,Calcium Regulation in the Cardiac Cell WP536,0.20166880971225104,1.3724139926506755,2.1974111341056197,"['RYR2', 'ADCY9', 'GJC2', 'PRKCB', 'PRKAR2B', 'PRKCE', 'ITPR2', 'PRKCQ', 'CACNA1D', 'CACNA1C', 'SLC8A1']",0.4913725715707546,0,0,11
188,Galanin receptor pathway WP4970,0.20276593151718417,2.6652351738241307,4.2529237943556994,"['PPARG', 'PPARGC1A']",0.4913725715707546,0,0,2
189,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.20374451058788237,1.667051282051282,2.6520926620538794,"['VAV3', 'ANXA5', 'NRG1', 'PTK2', 'NFKB1']",0.4913725715707546,0,0,5
190,G Protein Signaling Pathways WP35,0.20384451659048772,1.462314673882406,2.3256619661342075,"['GNA13', 'ADCY9', 'PRKCB', 'PRKAR2B', 'PDE4D', 'PRKCE', 'PRKCQ', 'AKAP6']",0.4913725715707546,0,0,8
191,Wnt Signaling Pathway WP363,0.21649168609820826,1.626266416510319,2.4885179667278385,"['GSK3B', 'APC', 'PRKCB', 'PPARG', 'PIP5K1B']",0.5191266609056513,0,0,5
192,Fatty acid transporters WP5061,0.22918967160216733,2.4227551589514777,3.5692158812281165,"['ACSL6', 'ACSL4']",0.5410766473906837,0,0,2
193,Omega-9 FA synthesis WP4724,0.22918967160216733,2.4227551589514777,3.5692158812281165,"['SCD', 'ACSL4']",0.5410766473906837,0,0,2
194,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.22918967160216733,2.4227551589514777,3.5692158812281165,"['GSK3B', 'PIK3CA']",0.5410766473906837,0,0,2
195,Cell migration and invasion through p75NTR WP4561,0.23342302762631062,1.904079543792952,2.770250854585652,"['TRIO', 'AKT3', 'EFNA5']",0.5482448546300014,0,0,3
196,Cardiac Hypertrophic Response WP2795,0.24268409143343425,1.550387596899225,2.195340646006021,"['GSK3B', 'MAP2K4', 'EGF', 'NRG1', 'NFKB1']",0.5613601710934994,0,0,5
197,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.24268409143343425,1.550387596899225,2.195340646006021,"['PLCB4', 'PRKCB', 'PRKCE', 'PRKCQ', 'NFKB1']",0.5613601710934994,0,0,5
198,Notch Signaling Pathway Netpath WP61,0.24268409143343425,1.550387596899225,2.195340646006021,"['GSK3B', 'MAML2', 'JAK2', 'HIF1A', 'NFKB1']",0.5613601710934994,0,0,5
199,Cells and molecules involved in local acute inflammatory response  WP4493,0.2516021584392621,4.439904664623766,6.1266518646363455,['ITGB1'],0.5698415170899871,0,0,1
200,Fatty Acid Omega Oxidation WP206,0.2516021584392621,4.439904664623766,6.1266518646363455,['ALDH1A1'],0.5698415170899871,0,0,1
201,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.2516021584392621,4.439904664623766,6.1266518646363455,['SLIT2'],0.5698415170899871,0,0,1
202,Vitamin B6-dependent and responsive disorders WP4228,0.2516021584392621,4.439904664623766,6.1266518646363455,['AASS'],0.5698415170899871,0,0,1
203,Ethanol effects on histone modifications WP3996,0.2525716767887934,1.817390899785987,2.5008392888165583,"['KAT2B', 'ACSS2', 'ALDH1A1']",0.5698415170899871,0,0,3
204,Differentiation of white and brown adipocyte WP2895,0.25581710795439877,2.220688479890934,3.0274479758462762,"['PPARG', 'PPARGC1A']",0.5715328558200714,0,0,2
205,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.25581710795439877,2.220688479890934,3.0274479758462762,"['NFKBIA', 'NFKB1']",0.5715328558200714,0,0,2
206,MECP2 and Associated Rett Syndrome WP3584,0.2643434093051709,1.4286080962158991,1.9007719698311007,"['FUT8', 'GRID1', 'OPRK1', 'IGF1R', 'CDON', 'FKBP5']",0.5877149585522732,0,0,6
207,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.26965822207444784,1.4812535612535613,1.9413308670310492,"['ITGB1', 'LAMA5', 'TRPC6', 'ITGAV', 'PTK2']",0.5959099726851532,0,0,5
208,Oxidation by Cytochrome P450 WP43,0.27193271679300657,1.7382403987361488,2.263537704114681,"['CYB5R4', 'CYP2U1', 'CYP2C18']",0.5959099726851532,0,0,3
209,The influence of laminopathies on Wnt signaling WP4844,0.27193271679300657,1.7382403987361488,2.263537704114681,"['GSK3B', 'APC', 'PPARG']",0.5959099726851532,0,0,3
210,Male infertility WP4673,0.28223741168863203,1.3170756490372402,1.6661094898961013,"['CREBBP', 'DDX4', 'SLC16A7', 'HORMAD1', 'CHD2', 'CDC42BPA', 'CLOCK', 'REC8']",0.6036709289730676,0,0,8
211,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.28249089419016304,2.0497089822243195,2.591055493655833,"['RARB', 'PPARG']",0.6036709289730676,0,0,2
212,Overview of interferons-mediated signaling pathway WP4558,0.28249089419016304,2.0497089822243195,2.591055493655833,"['PIK3CA', 'JAK2']",0.6036709289730676,0,0,2
213,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.28249089419016304,2.0497089822243195,2.591055493655833,"['ANXA5', 'PKD1']",0.6036709289730676,0,0,2
214,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.28249089419016304,2.0497089822243195,2.591055493655833,"['IDH1', 'ACO1']",0.6036709289730676,0,0,2
215,AGE/RAGE pathway WP2324,0.28338264133015184,1.4489409141583054,1.8270524854474262,"['NFKBIA', 'PRKCB', 'JAK2', 'HIF1A', 'NFKB1']",0.6036709289730676,0,0,5
216,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.28876918354890885,1.3791333286129008,1.7130595478563395,"['MAPK10', 'GSK3B', 'APC', 'DCC', 'AKT3', 'BRAF']",0.6045740039437023,0,0,6
217,T-cell receptor (TCR) signaling pathway WP69,0.28876918354890885,1.3791333286129008,1.7130595478563395,"['VAV3', 'NFKBIA', 'MAP3K8', 'PRKCQ', 'SOS1', 'NFKB1']",0.6045740039437023,0,0,6
218,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2890866962088882,1.523185011709602,1.8903162372206423,"['ACAN', 'COL10A1', 'SLC38A2', 'IGF1R']",0.6045740039437023,0,0,4
219,Endochondral Ossification WP474,0.2890866962088882,1.523185011709602,1.8903162372206423,"['ACAN', 'COL10A1', 'SLC38A2', 'IGF1R']",0.6045740039437023,0,0,4
220,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2914431460900694,1.6656857727737973,2.0536411980460603,"['NFKBIA', 'TRAF3', 'NFKB1']",0.6051950930347529,0,0,3
221,3q29 copy number variation syndrome WP4906,0.29723586508613653,1.4180032733224222,1.7203631141775833,"['CEP350', 'PXN', 'PIK3R3', 'NF2', 'HIF1A']",0.6051950930347529,0,0,5
222,Cytokines and Inflammatory Response WP530,0.3039189331833912,3.3296731358529112,3.965621660062131,['IL15'],0.6051950930347529,0,0,1
223,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.3039189331833912,3.3296731358529112,3.965621660062131,['HIF1A'],0.6051950930347529,0,0,1
224,LTF danger signal response pathway WP4478,0.3039189331833912,3.3296731358529112,3.965621660062131,['NFKB1'],0.6051950930347529,0,0,1
225,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3039189331833912,3.3296731358529112,3.965621660062131,['EGF'],0.6051950930347529,0,0,1
226,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3039189331833912,3.3296731358529112,3.965621660062131,['HIF1A'],0.6051950930347529,0,0,1
227,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.3039189331833912,3.3296731358529112,3.965621660062131,['SIX4'],0.6051950930347529,0,0,1
228,Mitochondrial fatty acid synthesis pathway WP4317,0.3039189331833912,3.3296731358529112,3.965621660062131,['ACACA'],0.6051950930347529,0,0,1
229,PTF1A related regulatory pathway WP4147,0.3039189331833912,3.3296731358529112,3.965621660062131,['KAT2B'],0.6051950930347529,0,0,1
230,SARS-CoV-2 and COVID-19 Pathway WP4846,0.3039189331833912,3.3296731358529112,3.965621660062131,['NRP1'],0.6051950930347529,0,0,1
231,Kallmann's Syndrome WP5074,0.3090746405470653,1.9031551270815075,2.2346323679403897,"['PIK3CA', 'PRKCQ']",0.609093375450035,0,0,2
232,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.3090746405470653,1.9031551270815075,2.2346323679403897,"['SCD', 'PPARGC1A']",0.609093375450035,0,0,2
233,Prion disease pathway WP3995,0.3110435167786223,1.598935516888434,1.8672727947366856,"['CHD2', 'NFKB1', 'PTK2']",0.609093375450035,0,0,3
234,Pathways affected in adenoid cystic carcinoma WP3651,0.3111961787233803,1.3883547008547008,1.6206705446717817,"['CREBBP', 'PIK3CA', 'MAGI2', 'ERBIN', 'ARID5B']",0.609093375450035,0,0,5
235,Androgen receptor signaling pathway WP138,0.3141457688344731,1.2960631494804156,1.5007091474834438,"['NCOA1', 'GSK3B', 'NCOA2', 'KAT2B', 'CREBBP', 'PLPP1', 'PTK2']",0.6122500516008028,0,0,7
236,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.322017626264832,1.237049699003047,1.4017616231693388,"['RET', 'RYR2', 'CREBBP', 'MAP2', 'PRKAR2B', 'NR3C1', 'HIF1A', 'PPARGC1A', 'NFKB1']",0.6249325119885298,0,0,9
237,Acute viral myocarditis WP4298,0.32524224949149255,1.3599162742019886,1.5274375485561127,"['GSK3B', 'LAMA2', 'CASP6', 'ABL2', 'SOS1']",0.6258863456600992,0,0,5
238,Neural Crest Differentiation WP2064,0.32524224949149255,1.3599162742019886,1.5274375485561127,"['ITGB1', 'GSK3B', 'MITF', 'NFKB1', 'CDH7']",0.6258863456600992,0,0,5
239,Vitamin A and carotenoid metabolism WP716,0.33067803919000593,1.5373198960711756,1.70121367510584,"['CRABP2', 'ALDH1A1', 'RARB']",0.6336842759373336,0,0,3
240,Ebstein-Barr virus LMP1 signaling WP262,0.33545075818726916,1.7761417859577369,1.94004433604575,"['NFKBIA', 'NFKB1']",0.6374956317417811,0,0,2
241,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.33545075818726916,1.7761417859577369,1.94004433604575,"['TGFBR3', 'LTBP1']",0.6374956317417811,0,0,2
242,Energy Metabolism WP1541,0.33756511154864993,1.4026100086281277,1.523230071023198,"['NCOA1', 'GSK3B', 'PPARG', 'PPARGC1A']",0.6388628970631474,0,0,4
243,ACE Inhibitor Pathway WP554,0.35258196826863814,2.6635342185903985,2.7766602425635445,['NR3C2'],0.6430577786808569,0,0,1
244,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.35258196826863814,2.6635342185903985,2.7766602425635445,['HSD11B2'],0.6430577786808569,0,0,1
245,EDA signaling in hair follicle development WP3930,0.35258196826863814,2.6635342185903985,2.7766602425635445,['EDA'],0.6430577786808569,0,0,1
246,Fluoroacetic acid toxicity WP4966,0.35258196826863814,2.6635342185903985,2.7766602425635445,['ACSS2'],0.6430577786808569,0,0,1
247,Glucuronidation WP698,0.35258196826863814,2.6635342185903985,2.7766602425635445,['PGM3'],0.6430577786808569,0,0,1
248,Nephrogenesis WP5052,0.35258196826863814,2.6635342185903985,2.7766602425635445,['GREB1L'],0.6430577786808569,0,0,1
249,Peroxiredoxin 2 induced ovarian failure WP4873,0.35258196826863814,2.6635342185903985,2.7766602425635445,['MAPK10'],0.6430577786808569,0,0,1
250,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.35258196826863814,2.6635342185903985,2.7766602425635445,['IGF1R'],0.6430577786808569,0,0,1
251,Copper homeostasis WP3286,0.35382218390300424,1.3665405632618748,1.4197820732924333,"['GSK3B', 'ATP7B', 'PIK3CA', 'APC']",0.6430577786808569,0,0,4
252,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.35382218390300424,1.3665405632618748,1.4197820732924333,"['ADCY9', 'TMEM43', 'SOS1', 'SOS2']",0.6430577786808569,0,0,4
253,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.36151850181816536,1.6650051124744376,1.6940462282273632,"['SGPL1', 'ST6GALNAC3']",0.6467791946590614,0,0,2
254,NAD+ biosynthetic pathways WP3645,0.36151850181816536,1.6650051124744376,1.6940462282273632,"['TNKS', 'QPRT']",0.6467791946590614,0,0,2
255,Toll-like Receptor Signaling related to MyD88 WP3858,0.36151850181816536,1.6650051124744376,1.6940462282273632,"['TRAF3', 'NFKB1']",0.6467791946590614,0,0,2
256,TYROBP causal network in microglia WP3945,0.36151850181816536,1.6650051124744376,1.6940462282273632,"['MAF', 'SFT2D2']",0.6467791946590614,0,0,2
257,IL-5 signaling pathway WP127,0.369844939356788,1.4272920017546424,1.4196865963993737,"['GSK3B', 'JAK2', 'SOS1']",0.6569609558712233,0,0,3
258,Glucocorticoid Receptor Pathway WP2880,0.3700784423903397,1.3322745901639343,1.3243346191051169,"['TGFBR3', 'FGD4', 'NR3C1', 'MFGE8']",0.6569609558712233,0,0,4
259,Gastric Cancer Network 1 WP2361,0.3871921937427317,1.5669433417538794,1.4867692512482078,"['NUP107', 'APC']",0.673901456532652,0,0,2
260,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.3871921937427317,1.5669433417538794,1.4867692512482078,"['CREBBP', 'ZFX']",0.673901456532652,0,0,2
261,Striated Muscle Contraction Pathway WP383,0.3871921937427317,1.5669433417538794,1.4867692512482078,"['MYOM1', 'MYBPC1']",0.673901456532652,0,0,2
262,Hedgehog Signaling Pathway WP4249,0.38928428417057037,1.3779691525782656,1.3000386509519959,"['GRK3', 'FBXL17', 'CDON']",0.673901456532652,0,0,3
263,Caloric restriction and aging WP4191,0.39784619316773734,2.2194416070820564,2.04563668587344,['PPARGC1A'],0.673901456532652,0,0,1
264,Insulin signaling in adipocytes (diabetic condition) WP3635,0.39784619316773734,2.2194416070820564,2.04563668587344,['TBC1D4'],0.673901456532652,0,0,1
265,Insulin signaling in adipocytes (normal condition) WP3634,0.39784619316773734,2.2194416070820564,2.04563668587344,['TBC1D4'],0.673901456532652,0,0,1
266,Liver X receptor pathway WP2874,0.39784619316773734,2.2194416070820564,2.04563668587344,['SCD'],0.673901456532652,0,0,1
267,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.39784619316773734,2.2194416070820564,2.04563668587344,['LDLRAP1'],0.673901456532652,0,0,1
268,NAD Biosynthesis II (from tryptophan) WP2485,0.39784619316773734,2.2194416070820564,2.04563668587344,['QPRT'],0.673901456532652,0,0,1
269,Sulfation Biotransformation Reaction WP692,0.39784619316773734,2.2194416070820564,2.04563668587344,['PAPSS1'],0.673901456532652,0,0,1
270,Genes related to primary cilium development (based on CRISPR) WP4536,0.3994000509752111,1.1586151368760065,1.0633673913074149,"['C2CD3', 'TTC21B', 'WDR19', 'SASS6', 'SCLT1', 'BBS9', 'KIFAP3', 'TTBK2']",0.673901456532652,0,0,8
271,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4085716267041119,1.3319344933469806,1.1921986341040582,"['MAPK10', 'MAP2K4', 'RPS6KA2']",0.673901456532652,0,0,3
272,Parkinson's disease pathway WP2371,0.4085716267041119,1.3319344933469806,1.1921986341040582,"['ATXN2', 'CASP6', 'UBE2G1']",0.673901456532652,0,0,3
273,Type 2 papillary renal cell carcinoma WP4241,0.4085716267041119,1.3319344933469806,1.1921986341040582,"['CREBBP', 'CTSK', 'HIF1A']",0.673901456532652,0,0,3
274,Complement and Coagulation Cascades WP558,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['PROS1', 'KLKB1']",0.673901456532652,0,0,2
275,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['PIK3CA', 'NFKB1']",0.673901456532652,0,0,2
276,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['NR3C1', 'JAK2']",0.673901456532652,0,0,2
277,PKC-gamma calcium signaling pathway in ataxia WP4760,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['PLCB4', 'PDK1']",0.673901456532652,0,0,2
278,SARS-CoV-2 mitochondrial interactions WP5038,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['TRAF3', 'NFKB1']",0.673901456532652,0,0,2
279,Vitamin B12 metabolism WP1533,0.4123996133590939,1.4797773233356055,1.3107312086489316,"['CUBN', 'NFKB1']",0.673901456532652,0,0,2
280,VEGFA-VEGFR2 Signaling Pathway WP3888,0.41344334232937546,1.061724038666902,0.9377516122223296,"['ITGB1', 'GSK3B', 'EPB41', 'PXN', 'ACACB', 'GIGYF2', 'SLC8A1', 'ACACA', 'FGD5', 'RAP1A', 'RICTOR', 'ITGAV', 'LRRFIP2', 'ASCC3', 'MAP2K4', 'CREBBP', 'PRKCB', 'PRKCE', 'EIF2AK3', 'GAB1', 'NFKB1', 'PTK2', 'NFKBIA', 'INPP4B', 'AFDN', 'PIK3CA', 'KATNAL2']",0.673901456532652,0,0,27
281,Kit receptor signaling pathway WP304,0.4185719536074546,1.2390392680137248,1.0790873171724138,"['PRKCB', 'MITF', 'JAK2', 'SOS1']",0.673901456532652,0,0,4
282,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4185719536074546,1.2390392680137248,1.0790873171724138,"['NFKBIA', 'MAPK10', 'TRAF3', 'NFKB1']",0.673901456532652,0,0,4
283,p53 transcriptional gene network WP4963,0.4185719536074546,1.2390392680137248,1.0790873171724138,"['TIGAR', 'SESN1', 'FANCC', 'ERCC5']",0.673901456532652,0,0,4
284,Ferroptosis WP4313,0.42766947116172616,1.288869812130617,1.0947720057271275,"['ACSL6', 'ACSL4', 'GCLM']",0.673901456532652,0,0,3
285,Proximal tubule transport WP4917,0.42766947116172616,1.288869812130617,1.0947720057271275,"['SLC47A1', 'SLC7A8', 'AQP1']",0.673901456532652,0,0,3
286,Genotoxicity pathway WP4286,0.43456175379206013,1.2107861400894189,1.0090900167955459,"['TIGAR', 'RAPGEF2', 'LRRFIP2', 'PPM1D']",0.673901456532652,0,0,4
287,IL-1 signaling pathway WP195,0.43456175379206013,1.2107861400894189,1.0090900167955459,"['NFKBIA', 'MAP2K4', 'PELI2', 'NFKB1']",0.673901456532652,0,0,4
288,Cardiac Progenitor Differentiation WP2406,0.43708053781294687,1.40178667527715,1.1601716453398165,"['GSK3B', 'NRG1']",0.673901456532652,0,0,2
289,Differentiation Pathway WP2848,0.43708053781294687,1.40178667527715,1.1601716453398165,"['EGF', 'WNT5A']",0.673901456532652,0,0,2
290,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.43708053781294687,1.40178667527715,1.1601716453398165,"['ADAMTS2', 'PLOD2']",0.673901456532652,0,0,2
291,White fat cell differentiation WP4149,0.43708053781294687,1.40178667527715,1.1601716453398165,"['PPARG', 'NR3C1']",0.673901456532652,0,0,2
292,Blood Clotting Cascade WP272,0.4399487674743732,1.9022325988618123,1.5619174733937748,['KLKB1'],0.673901456532652,0,0,1
293,"Degradation pathway of sphingolipids, including diseases WP4153",0.4399487674743732,1.9022325988618123,1.5619174733937748,['GLB1'],0.673901456532652,0,0,1
294,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.4399487674743732,1.9022325988618123,1.5619174733937748,['ALDH1A1'],0.673901456532652,0,0,1
295,Iron metabolism in placenta WP2007,0.4399487674743732,1.9022325988618123,1.5619174733937748,['ACO1'],0.673901456532652,0,0,1
296,Leptin and adiponectin WP3934,0.4399487674743732,1.9022325988618123,1.5619174733937748,['ACACA'],0.673901456532652,0,0,1
297,NLR Proteins WP288,0.4399487674743732,1.9022325988618123,1.5619174733937748,['ERBIN'],0.673901456532652,0,0,1
298,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.4399487674743732,1.9022325988618123,1.5619174733937748,['NFKB1'],0.673901456532652,0,0,1
299,Vitamin B12 Disorders WP4271,0.4399487674743732,1.9022325988618123,1.5619174733937748,['CUBN'],0.673901456532652,0,0,1
300,Hepatitis C and Hepatocellular Carcinoma WP3646,0.446543763255931,1.2484966734902763,1.00656032812623,"['SOS1', 'HIF1A', 'NFKB1']",0.6772087535470741,0,0,3
301,IL-3 signaling pathway WP286,0.446543763255931,1.2484966734902763,1.00656032812623,"['PIK3CD', 'JAK2', 'SOS1']",0.6772087535470741,0,0,3
302,Netrin-UNC5B signaling pathway WP4747,0.446543763255931,1.2484966734902763,1.00656032812623,"['PIK3CA', 'NEO1', 'PTK2']",0.6772087535470741,0,0,3
303,Senescence and Autophagy in Cancer WP615,0.45312292454726566,1.1254880411834456,0.8909271423201379,"['UVRAG', 'GSK3B', 'ATG10', 'COL10A1', 'BRAF', 'IGF1R']",0.6849184800087382,0,0,6
304,Nanoparticle triggered autophagic cell death WP2509,0.4611854208871393,1.3315950920245399,1.0305948157317295,"['UVRAG', 'ATG10']",0.6907372427327145,0,0,2
305,Physiological and pathological hypertrophy of the heart WP1528,0.4611854208871393,1.3315950920245399,1.0305948157317295,"['PRKCB', 'PRKCE']",0.6907372427327145,0,0,2
306,Circadian rhythm related genes WP3594,0.4614969351008966,1.0693995615918284,0.8269451499335482,"['MAPK10', 'NCOA2', 'GSK3B', 'HOMER1', 'KCND2', 'DYRK1A', 'PPARG', 'RORB', 'CLOCK', 'PPARGC1A', 'HS3ST2']",0.6907372427327145,0,0,11
307,Glycogen Synthesis and Degradation WP500,0.46516376954266403,1.210570391737229,0.9265291071262091,"['GYS2', 'GSK3B', 'PHKA1']",0.6911266781165427,0,0,3
308,Nuclear Receptors Meta-Pathway WP2882,0.47471076094392795,1.0474678391141508,0.7804154785665603,"['NCOA1', 'NCOA2', 'NRG1', 'NR3C1', 'SLC5A3', 'TGFBR3', 'KAT2B', 'FGD4', 'SCD', 'ME1', 'MFGE8', 'GCLM', 'PPARGC1A', 'FKBP5']",0.6911266781165427,0,0,14
309,15q11.2 copy number variation syndrome WP4940,0.47911031837604307,1.6643258426966292,1.224651561821242,['CYFIP1'],0.6911266781165427,0,0,1
310,Autosomal recessive Osteopetrosis pathways WP4788,0.47911031837604307,1.6643258426966292,1.224651561821242,['NFKB1'],0.6911266781165427,0,0,1
311,Cytosine methylation WP3585,0.47911031837604307,1.6643258426966292,1.224651561821242,['IDH1'],0.6911266781165427,0,0,1
312,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.47911031837604307,1.6643258426966292,1.224651561821242,['PRKCQ'],0.6911266781165427,0,0,1
313,Genes targeted by miRNAs in adipocytes WP1992,0.47911031837604307,1.6643258426966292,1.224651561821242,['PTBP2'],0.6911266781165427,0,0,1
314,Matrix Metalloproteinases WP129,0.47911031837604307,1.6643258426966292,1.224651561821242,['MMP15'],0.6911266781165427,0,0,1
315,miR-509-3p alteration of YAP1/ECM axis WP3967,0.47911031837604307,1.6643258426966292,1.224651561821242,['TEAD1'],0.6911266781165427,0,0,1
316,Serotonin and anxiety-related events WP3944,0.47911031837604307,1.6643258426966292,1.224651561821242,['PRKCB'],0.6911266781165427,0,0,1
317,Trans-sulfuration pathway WP2333,0.47911031837604307,1.6643258426966292,1.224651561821242,['GCLM'],0.6911266781165427,0,0,1
318,16p11.2 proximal deletion syndrome WP4949,0.4798652481245865,1.1096581196581197,0.814766416176142,"['QPRT', 'CCDC6', 'PPARG', 'NR3C1', 'NFKB1']",0.6911266781165427,0,0,5
319,Cannabinoid receptor signaling WP3869,0.48467419704118203,1.2680884214626547,0.9184490180242093,"['MAPK10', 'PRKAR2B']",0.6915289166506584,0,0,2
320,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.48467419704118203,1.2680884214626547,0.9184490180242093,"['RAP1A', 'TEAD1']",0.6915289166506584,0,0,2
321,Signal transduction through IL1R WP4496,0.48467419704118203,1.2680884214626547,0.9184490180242093,"['NFKBIA', 'NFKB1']",0.6915289166506584,0,0,2
322,Cell cycle WP179,0.4991660520615826,1.059107259646828,0.735885166359236,"['GSK3B', 'STAG1', 'RBL1', 'TFDP2', 'CDC27', 'ORC2', 'ANAPC10']",0.709993949826723,0,0,7
323,Neovascularisation processes WP4331,0.5075152009642052,1.2103550845882134,0.8208974537386677,"['HIF1A', 'NFKB1']",0.7111913558258711,0,0,2
324,Oxidative Stress WP408,0.5075152009642052,1.2103550845882134,0.8208974537386677,"['MAPK10', 'NFKB1']",0.7111913558258711,0,0,2
325,Peptide GPCRs WP24,0.5075152009642052,1.2103550845882134,0.8208974537386677,"['MC1R', 'OPRK1']",0.7111913558258711,0,0,2
326,Sphingolipid pathway WP1422,0.5075152009642052,1.2103550845882134,0.8208974537386677,"['SGPL1', 'PLPP1']",0.7111913558258711,0,0,2
327,Hedgehog Signaling Pathway Netpath WP47,0.5155360919960463,1.4792872545681535,0.9800987592837671,['STK36'],0.7111913558258711,0,0,1
328,ID signaling pathway WP53,0.5155360919960463,1.4792872545681535,0.9800987592837671,['RBL1'],0.7111913558258711,0,0,1
329,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5155360919960463,1.4792872545681535,0.9800987592837671,['NFKB1'],0.7111913558258711,0,0,1
330,Neuroinflammation WP4919,0.5155360919960463,1.4792872545681535,0.9800987592837671,['NFKBIA'],0.7111913558258711,0,0,1
331,Osteoclast Signaling WP12,0.5155360919960463,1.4792872545681535,0.9800987592837671,['CTSK'],0.7111913558258711,0,0,1
332,Transcriptional cascade regulating adipogenesis WP4211,0.5155360919960463,1.4792872545681535,0.9800987592837671,['PPARG'],0.7111913558258711,0,0,1
333,Lung fibrosis WP3624,0.529684190833929,1.1576420378767671,0.735651782639382,"['EGF', 'FAM13A']",0.7263334113830524,0,0,2
334,Tryptophan metabolism WP465,0.529684190833929,1.1576420378767671,0.735651782639382,"['ALDH1A1', 'CYP2C18']",0.7263334113830524,0,0,2
335,Histone Modifications WP2369,0.5365948363054195,1.0793659575645247,0.6719182221435553,"['SETD5', 'AEBP2', 'SMYD3']",0.7336132388892003,0,0,3
336,Amino Acid metabolism WP3925,0.5465365196236834,1.0239053254437869,0.6185966505860988,"['ARG2', 'IDH1', 'ALDH1A1', 'GCLM', 'GLS']",0.7336238985015165,0,0,5
337,Joubert Syndrome WP4656,0.5465365196236834,1.0239053254437869,0.6185966505860988,"['INVS', 'AHI1', 'KIAA0586', 'CSPP1', 'BBS9']",0.7336238985015165,0,0,5
338,Retinoblastoma gene in cancer WP2446,0.5465365196236834,1.0239053254437869,0.6185966505860988,"['BARD1', 'ANLN', 'TFDP2', 'CCDC6', 'POLE']",0.7336238985015165,0,0,5
339,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5494170244236248,1.3312563840653728,0.7972861449030112,['NFKB1'],0.7336238985015165,0,0,1
340,FOXA2 pathway WP5066,0.5494170244236248,1.3312563840653728,0.7972861449030112,['ACACA'],0.7336238985015165,0,0,1
341,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5494170244236248,1.3312563840653728,0.7972861449030112,['CDK8'],0.7336238985015165,0,0,1
342,Hypertrophy Model WP516,0.5494170244236248,1.3312563840653728,0.7972861449030112,['ZEB1'],0.7336238985015165,0,0,1
343,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5494170244236248,1.3312563840653728,0.7972861449030112,['STAG1'],0.7336238985015165,0,0,1
344,Intraflagellar transport proteins binding to dynein WP4532,0.5719410795538324,1.0648670756646217,0.5949617878335849,"['WDR19', 'DYNC1I1']",0.7580235848656772,0,0,2
345,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5719410795538324,1.0648670756646217,0.5949617878335849,"['NFKBIA', 'ERBIN']",0.7580235848656772,0,0,2
346,Cancer immunotherapy by PD-1 blockade WP4585,0.5809307386197657,1.2101402172903706,0.657255880586215,['NFKB1'],0.7580235848656772,0,0,1
347,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5809307386197657,1.2101402172903706,0.657255880586215,['RYR2'],0.7580235848656772,0,0,1
348,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5809307386197657,1.2101402172903706,0.657255880586215,['EGF'],0.7580235848656772,0,0,1
349,Ganglio Sphingolipid Metabolism WP1423,0.5809307386197657,1.2101402172903706,0.657255880586215,['ST8SIA1'],0.7580235848656772,0,0,1
350,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5809307386197657,1.2101402172903706,0.657255880586215,['ADCY9'],0.7580235848656772,0,0,1
351,Serotonin and anxiety WP3947,0.5809307386197657,1.2101402172903706,0.657255880586215,['PRKCB'],0.7580235848656772,0,0,1
352,7q11.23 copy number variation syndrome WP4932,0.5963811746568994,0.961876252443037,0.4971700395615189,"['GRIP1', 'CLIP2', 'EIF2AK3', 'NRG1', 'ACACB', 'ACACA']",0.7759732329342611,0,0,6
353,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6022658576100008,0.9737623885962503,0.4937523608748348,"['PPP1R13B', 'PPP1R3B', 'EIF2AK3']",0.7814100928764317,0,0,3
354,BMP Signaling Pathway in Eyelid Development WP3927,0.6102424718684453,1.109210078311202,0.5478376441229149,['DKK2'],0.7828881011645601,0,0,1
355,Omega-3/Omega-6 FA synthesis WP4723,0.6102424718684453,1.109210078311202,0.5478376441229149,['ACSL4'],0.7828881011645601,0,0,1
356,Transcription co-factors SKI and SKIL protein partners WP4533,0.6102424718684453,1.109210078311202,0.5478376441229149,['TEAD1'],0.7828881011645601,0,0,1
357,Tryptophan catabolism leading to NAD+ production WP4210,0.6102424718684453,1.109210078311202,0.5478376441229149,['QPRT'],0.7828881011645601,0,0,1
358,Bladder cancer WP2828,0.6300161095326287,0.9505550686532281,0.43916584198192915,"['EGF', 'BRAF']",0.7999389581726499,0,0,2
359,Imatinib and Chronic Myeloid Leukemia WP3640,0.637505938281697,1.0238076530211362,0.4609096945193364,['PDGFRB'],0.7999389581726499,0,0,1
360,Kennedy pathway from sphingolipids WP3933,0.637505938281697,1.0238076530211362,0.4609096945193364,['SGPL1'],0.7999389581726499,0,0,1
361,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.637505938281697,1.0238076530211362,0.4609096945193364,['GSK3B'],0.7999389581726499,0,0,1
362,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.637505938281697,1.0238076530211362,0.4609096945193364,['NFKB1'],0.7999389581726499,0,0,1
363,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.637505938281697,1.0238076530211362,0.4609096945193364,['GSK3B'],0.7999389581726499,0,0,1
364,Riboflavin and CoQ disorders WP5037,0.637505938281697,1.0238076530211362,0.4609096945193364,['PDSS2'],0.7999389581726499,0,0,1
365,SARS coronavirus and innate immunity WP4912,0.637505938281697,1.0238076530211362,0.4609096945193364,['TRAF3'],0.7999389581726499,0,0,1
366,Cholesterol Biosynthesis Pathway WP197,0.6628641320919291,0.9506055742010798,0.3908749800025711,['LSS'],0.8205183040489284,0,0,1
367,ERK Pathway in Huntington's Disease WP3853,0.6628641320919291,0.9506055742010798,0.3908749800025711,['EGF'],0.8205183040489284,0,0,1
368,Glycosaminoglycan degradation WP4815,0.6628641320919291,0.9506055742010798,0.3908749800025711,['GLB1'],0.8205183040489284,0,0,1
369,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6628641320919291,0.9506055742010798,0.3908749800025711,['QPRT'],0.8205183040489284,0,0,1
370,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.6628641320919291,0.9506055742010798,0.3908749800025711,['ACSL4'],0.8205183040489284,0,0,1
371,Target Of Rapamycin (TOR) Signaling WP1471,0.6652038940405436,0.8870483980913428,0.36161563820339787,"['ULK3', 'RICTOR']",0.821195103694256,0,0,2
372,G1 to S cell cycle control WP45,0.6752543539581976,0.8675848871879311,0.3406709471193881,"['TFDP2', 'ORC2', 'POLE']",0.8313615433141249,0,0,3
373,Amyotrophic lateral sclerosis (ALS) WP2447,0.681760798309579,0.858367966224685,0.3288205260652799,"['ALS2', 'NEFH']",0.8330142295682311,0,0,2
374,Notch Signaling WP268,0.681760798309579,0.858367966224685,0.3288205260652799,"['KAT2B', 'CREBBP']",0.8330142295682311,0,0,2
375,Statin inhibition of cholesterol production WP430,0.6864500740468079,0.8871637725570309,0.3337703352326116,['SOAT1'],0.8330142295682311,0,0,1
376,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6864500740468079,0.8871637725570309,0.3337703352326116,['TRAF3'],0.8330142295682311,0,0,1
377,Urea cycle and metabolism of amino groups WP497,0.6864500740468079,0.8871637725570309,0.3337703352326116,['ARG2'],0.8330142295682311,0,0,1
378,Nonalcoholic fatty liver disease WP4396,0.687509560648016,0.87895792946298,0.3293275554513394,"['GSK3B', 'PIK3CA', 'AKT3', 'EIF2AK3', 'PIK3R3', 'PIK3CD', 'PIK3CB', 'NFKB1']",0.8330142295682311,0,0,8
379,ATM Signaling Pathway WP2516,0.6976414897001509,0.8314800613496932,0.29937434058078044,"['NFKBIA', 'CRADD']",0.838634651660549,0,0,2
380,DNA Replication WP466,0.6976414897001509,0.8314800613496932,0.29937434058078044,"['ORC2', 'POLE']",0.838634651660549,0,0,2
381,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6976414897001509,0.8314800613496932,0.29937434058078044,"['NFKBIA', 'NFKB1']",0.838634651660549,0,0,2
382,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7083875066985528,0.8316521961184883,0.28672374536981265,['BRAF'],0.8448996824685864,0,0,1
383,Nanomaterial induced apoptosis WP2507,0.7083875066985528,0.8316521961184883,0.28672374536981265,['CASP6'],0.8448996824685864,0,0,1
384,Triacylglyceride synthesis WP325,0.7083875066985528,0.8316521961184883,0.28672374536981265,['PLPP1'],0.8448996824685864,0,0,1
385,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7128595168809415,0.8062217264671252,0.27288260061571956,"['MAP2K4', 'CASP6']",0.8458281314286819,0,0,2
386,"GPCRs, Other WP117",0.7128595168809415,0.8062217264671252,0.27288260061571956,"['ADGRV1', 'HTR1F']",0.8458281314286819,0,0,2
387,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7274298378105445,0.7824491759894142,0.2490048476194343,"['TRAF3', 'NFKB1']",0.8558628864404806,0,0,2
388,Immune response to tuberculosis WP4197,0.7287915408554311,0.7826713933785976,0.24761182339299273,['JAK2'],0.8558628864404806,0,0,1
389,Monoamine Transport WP727,0.7287915408554311,0.7826713933785976,0.24761182339299273,['AMPH'],0.8558628864404806,0,0,1
390,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7287915408554311,0.7826713933785976,0.24761182339299273,['GCLM'],0.8558628864404806,0,0,1
391,DNA IR-damage and cellular response via ATR WP4016,0.7403811153890902,0.7937362368485442,0.23858933780539032,"['BARD1', 'RMI1', 'PPM1D', 'MCPH1']",0.8626657928863213,0,0,4
392,Common Pathways Underlying Drug Addiction WP2636,0.7413685571782702,0.7600350569675723,0.22744611447114418,"['RAP1A', 'PRKCB']",0.8626657928863213,0,0,2
393,Canonical and non-canonical Notch signaling WP3845,0.7477692571525536,0.7391329020542504,0.21483698156436126,['MAML2'],0.8626657928863213,0,0,1
394,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7477692571525536,0.7391329020542504,0.21483698156436126,['ATG10'],0.8626657928863213,0,0,1
395,IL-7 signaling pathway WP205,0.7477692571525536,0.7391329020542504,0.21483698156436126,['GSK3B'],0.8626657928863213,0,0,1
396,Mitochondrial Gene Expression WP391,0.7477692571525536,0.7391329020542504,0.21483698156436126,['PPARGC1A'],0.8626657928863213,0,0,1
397,Monoamine GPCRs WP58,0.7477692571525536,0.7391329020542504,0.21483698156436126,['HTR1F'],0.8626657928863213,0,0,1
398,Metapathway biotransformation Phase I and II WP702,0.7541054442912298,0.7911477411477411,0.22328014766236107,"['CYP2U1', 'KCNAB3', 'CYP2C18', 'HS3ST1', 'HS3ST2']",0.866288855903218,0,0,5
399,Aryl Hydrocarbon Receptor Netpath WP2586,0.7546926932431964,0.7388661667802772,0.20794992335855814,"['RET', 'NFKB1']",0.866288855903218,0,0,2
400,Vitamin D Receptor Pathway WP2877,0.7598931101220234,0.7706105963411737,0.21159233114742632,"['PRKCQ', 'EFNA5', 'HIF1A', 'SLC8A1']",0.8700776110897168,0,0,4
401,Signal Transduction of S1P Receptor WP26,0.7654202655674021,0.7001774098166765,0.18717858748021196,['AKT3'],0.8741931567291801,0,0,1
402,Metabolic reprogramming in colon cancer WP4290,0.7674199720841904,0.7188415409274305,0.19029250608533702,"['TIGAR', 'GLS']",0.8741931567291801,0,0,2
403,"GPCRs, Class A Rhodopsin-like WP455",0.7692136291743659,0.759543325526932,0.19929395032169403,"['MC1R', 'HTR1F', 'RRH', 'OPRK1']",0.8741931567291801,0,0,4
404,Prader-Willi and Angelman Syndrome WP3998,0.7795686455184767,0.6998708427510494,0.17427800955325407,"['CYFIP1', 'SLC45A2']",0.8819740138665816,0,0,2
405,Sphingolipid Metabolism (general overview) WP4725,0.7818372262660089,0.6651174668028601,0.16369120219105693,['SGPL1'],0.8819740138665816,0,0,1
406,Type II interferon signaling (IFNG) WP619,0.7818372262660089,0.6651174668028601,0.16369120219105693,['JAK2'],0.8819740138665816,0,0,1
407,Cytosolic DNA-sensing pathway WP4655,0.7911573313397694,0.6818730008914058,0.15973449808405402,"['NFKBIA', 'NFKB1']",0.8839581137659616,0,0,2
408,7-oxo-C and 7beta-HC pathways WP5064,0.7971063340291312,0.6333965659808356,0.14363356020722312,['HSD11B2'],0.8839581137659616,0,0,1
409,DNA Mismatch Repair WP531,0.7971063340291312,0.6333965659808356,0.14363356020722312,['POLE'],0.8839581137659616,0,0,1
410,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7971063340291312,0.6333965659808356,0.14363356020722312,['MBD2'],0.8839581137659616,0,0,1
411,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7971063340291312,0.6333965659808356,0.14363356020722312,['RBL1'],0.8839581137659616,0,0,1
412,Sphingolipid Metabolism (integrated pathway) WP4726,0.7971063340291312,0.6333965659808356,0.14363356020722312,['SGPL1'],0.8839581137659616,0,0,1
413,Unfolded protein response WP4925,0.7971063340291312,0.6333965659808356,0.14363356020722312,['EIF2AK3'],0.8839581137659616,0,0,1
414,ATM Signaling Network in Development and Disease  WP3878,0.8022048735337053,0.6647750511247443,0.14651060478822708,"['PPM1D', 'NFKB1']",0.8853248965745472,0,0,2
415,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8022048735337053,0.6647750511247443,0.14651060478822708,"['ATG10', 'ACACA']",0.8853248965745472,0,0,2
416,16p11.2 distal deletion syndrome WP4950,0.8113077688167085,0.6045593834153589,0.12641808497119944,['JAK2'],0.8864515981076407,0,0,1
417,Hematopoietic Stem Cell Differentiation WP2849,0.8113077688167085,0.6045593834153589,0.12641808497119944,['ITGA2B'],0.8864515981076407,0,0,1
418,Integrated breast cancer pathway WP1984,0.81194597438727,0.7556881324208925,0.15742606641596887,"['BARD1', 'FER', 'RAP1A', 'RALGAPA1', 'ZMYND8', 'BRAF', 'NFKB1']",0.8864515981076407,0,0,7
419,Ciliary landscape WP4352,0.8148607429106663,0.7889883691741277,0.16153593854819256,"['MKLN1', 'CREBBP', 'TBC1D4', 'APC', 'WNK1', 'GLB1', 'EXOC6B', 'BBS9', 'CEP170', 'NFKB1', 'RPGR']",0.8864515981076407,0,0,11
420,DNA Repair Pathways Full Network WP4946,0.8167148922658695,0.737793748574036,0.1493775692672994,"['RAP1A', 'REV1', 'REV3L', 'FANCC', 'ERCC5', 'POLE']",0.8864515981076407,0,0,6
421,IL-18 signaling pathway WP4754,0.8211048612950275,0.7760294206306143,0.15295885510043686,"['NFKBIA', 'SLC4A7', 'GSK3B', 'ALS2', 'PRKCB', 'EPB41', 'TSHZ1', 'ITGA2B', 'ACACB', 'NFKB1']",0.8864515981076407,0,0,10
422,Nucleotide Excision Repair WP4753,0.8227523133127983,0.6330217158438017,0.12350258707299476,"['ERCC5', 'POLE']",0.8864515981076407,0,0,2
423,Phosphodiesterases in neuronal function WP4222,0.8227523133127983,0.6330217158438017,0.12350258707299476,"['ADCY9', 'PDE4D']",0.8864515981076407,0,0,2
424,Aryl Hydrocarbon Receptor Pathway WP2873,0.8245161152704257,0.5782297819425323,0.11157440438332238,['NCOA1'],0.8864515981076407,0,0,1
425,Photodynamic therapy-induced unfolded protein response WP3613,0.8245161152704257,0.5782297819425323,0.11157440438332238,['EIF2AK3'],0.8864515981076407,0,0,1
426,Pre-implantation embryo WP3527,0.8245161152704257,0.5782297819425323,0.11157440438332238,['NR3C2'],0.8864515981076407,0,0,1
427,Exercise-induced Circadian Regulation WP410,0.8322900051599429,0.618252722689875,0.11349533243038097,"['GFRA1', 'CLOCK']",0.8906280896337706,0,0,2
428,Interferon type I signaling pathways WP585,0.8322900051599429,0.618252722689875,0.11349533243038097,"['RAP1A', 'PIK3CD']",0.8906280896337706,0,0,2
429,Trans-sulfuration and one-carbon metabolism WP2525,0.8368007526740336,0.5540943139257746,0.09872258840230787,['GCLM'],0.8933677033209964,0,0,1
430,Endothelin Pathways WP2197,0.8482262178274085,0.5318896833503575,0.08755325043538294,['NPY'],0.9034595529417514,0,0,1
431,GABA receptor Signaling WP4159,0.8588525431385453,0.5113931012807418,0.07781256828145573,['GABRA3'],0.9096923284968568,0,0,1
432,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8588525431385453,0.5113931012807418,0.07781256828145573,['ITPR2'],0.9096923284968568,0,0,1
433,NRF2 pathway WP2884,0.8600366337099105,0.6477908836465414,0.09767409943634878,"['ME1', 'NRG1', 'GCLM', 'SLC5A3']",0.9096923284968568,0,0,4
434,Translation Factors WP107,0.8733564718280393,0.5536383776414451,0.07496899032210406,"['EIF2AK3', 'EIF4G3']",0.9216526822517097,0,0,2
435,Autophagy WP4923,0.8779272419731047,0.47479206187071354,0.06181391764039745,['UVRAG'],0.924346383502717,0,0,1
436,Base Excision Repair WP4752,0.8864758756134938,0.458384699376563,0.05523598284463511,['POLE'],0.9290754028168883,0,0,1
437,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8864758756134938,0.458384699376563,0.05523598284463511,['HIF1A'],0.9290754028168883,0,0,1
438,CAMKK2  Pathway WP4874,0.8944264143951476,0.44307116104868915,0.04943462088645475,['MAF'],0.9331373526035937,0,0,1
439,IL-2 signaling pathway WP49,0.8944264143951476,0.44307116104868915,0.04943462088645475,['SOS1'],0.9331373526035937,0,0,1
440,Folate Metabolism WP176,0.9018206633338148,0.42874559293551684,0.04430639800057441,['NFKB1'],0.9358979868129764,0,0,1
441,Mitochondrial CIV Assembly WP4922,0.9018206633338148,0.42874559293551684,0.04430639800057441,['COX10'],0.9358979868129764,0,0,1
442,Spinal Cord Injury WP2431,0.9032028606361038,0.5531815080177414,0.056318357693620175,"['ACAN', 'SLIT2', 'AQP1']",0.9358979868129764,0,0,3
443,p38 MAPK Signaling Pathway WP400,0.9086975083967253,0.4153153728294178,0.039763545649595285,['MAP2K4'],0.9394660470557565,0,0,1
444,Integrated Cancer Pathway WP1971,0.9317174068371357,0.36905572579729884,0.026101732599777237,['BARD1'],0.9610958836292975,0,0,1
445,Interleukin-11 Signaling Pathway WP2332,0.9365018336446039,0.3590536399525164,0.02355528287012319,['JAK2'],0.9638603141780417,0,0,1
446,One-carbon metabolism and related pathways WP3940,0.9409513317058891,0.3495779796785119,0.021276665387003582,['GCLM'],0.9662684078952852,0,0,1
447,Pathogenic Escherichia coli infection WP2272,0.9489376005496243,0.3320480081716037,0.01740337836159031,['ITGB1'],0.9701192434190355,0,0,1
448,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9489376005496243,0.3320480081716037,0.01740337836159031,['MAP2K4'],0.9701192434190355,0,0,1
449,Synaptic Vesicle Pathway WP2267,0.9589397899402246,0.30881060408105093,0.01294749919634574,['SLC17A6'],0.978161300206287,0,0,1
450,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9714519024257099,0.276536431733061,0.00800946845981484,['MCPH1'],0.9875707854534039,0,0,1
451,Selenium Micronutrient Network WP15,0.973453828170912,0.27087198515769945,0.0072877793351875985,['NFKB1'],0.9875707854534039,0,0,1
452,Pyrimidine metabolism WP4022,0.9746331769103463,0.35359236537150646,0.009085240277445924,"['NME7', 'POLE']",0.9875707854534039,0,0,2
453,mRNA Processing WP411,0.9794528620655064,0.43405670518677775,0.009011523848906336,"['CPSF1', 'SREK1', 'CLASRP', 'PTBP2']",0.9901938290034915,0,0,4
454,DNA damage response WP707,0.9815458479641597,0.24569666704498166,0.004576482289864084,['SESN1'],0.9901938290034915,0,0,1
455,miRNA regulation of DNA damage response WP1530,0.9840442693868121,0.23688530570553043,0.003810156525257281,['SESN1'],0.9905324733607911,0,0,1
456,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9889097982819708,0.21738475192149903,0.002424308772311985,['UBE2G1'],0.993247121958646,0,0,1
457,22q11.2 copy number variation syndrome WP4657,0.9974137443168076,0.16345729454343685,0.0004232899612507227,['AIFM3'],0.9982028711304731,0,0,1
458,Cytoplasmic Ribosomal Proteins WP477,0.9982028711304731,0.1538945768106991,0.0002768171995099612,['RPS6KA2'],0.9982028711304731,0,0,1
